// App-Quantinova.ai

247 : Duration of Bisphosphonate Therapy and the Risk of Atypical Femur Fracture in Rheumatic Disease Patients

Researchers

Presenter

  • Mary Bell

Principal Investigators

  • N/A

Medical Centers

  • Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • Univ of Toronto, Toronto, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoporosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved